CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-18 | Lee Sam President and Co-CEO | Grant or award · Stock Options (Right to Buy) | +30,000 | 30,000 | ||
| 2023-07-18 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Options (Right to Buy) | +7,333 | 7,333 | ||
| 2023-07-18 | Hassan Fred Director | Grant or award · Stock Options (Right to Buy) | +7,333 | 7,333 | ||
| 2023-07-18 | Rubin Steven D Director | Grant or award · Stock Options (Right to Buy) | +17,233 | 17,233 | ||
| 2023-04-04 | FROST PHILLIP MD ET AL Director | Purchase | +1,015,229 | $1.97 | $2.0M | 1,319,838 |
| 2022-07-25 | Japour Anthony J Director | Grant or award · Stock Options (Right to Buy) | +148,000 | 148,000 | ||
| 2022-07-25 | FROST PHILLIP MD ET AL Director | Grant or award · Stock Options (Right to Buy) | +220,000 | 220,000 | ||
| 2022-07-25 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Options (Right to Buy) | +80,000 | 80,000 | ||
| 2022-07-25 | Martin James Joseph Co- Interim CEO and CFO | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2022-07-25 | Rubin Steven D Director | Grant or award · Stock Options (Right to Buy) | +188,000 | 188,000 | ||
| 2022-07-25 | Lee Sam President and Co-Interim CEO | Grant or award · Stock Options (Right to Buy) | +300,000 | 300,000 | ||
| 2022-07-25 | Kornberg Roger D. Director | Grant or award · Stock Options (Right to Buy) | +280,000 | 280,000 | ||
| 2021-08-20 | PFENNIGER RICHARD C JR Director | Purchase | +40,000 | $1.03 | $41K | 40,000 |
| 2021-07-16 | Lee Sam President and Co-Interim CEO | Grant or award · Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2021-07-16 | FROST PHILLIP MD ET AL Director | Grant or award · Stock Options (Right to Buy) | +65,000 | 65,000 | ||
| 2021-07-16 | Kornberg Roger D. Director | Grant or award · Stock Options (Right to Buy) | +65,000 | 65,000 | ||
| 2021-07-16 | Martin James Joseph Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +250,000 | 250,000 | ||
| 2021-07-16 | Rubin Steven D Director | Grant or award · Stock Options (Right to Buy) | +88,000 | 88,000 | ||
| 2021-07-16 | PFENNIGER RICHARD C JR Director | Grant or award · Stock Options (Right to Buy) | +50,000 | 50,000 | ||
| 2021-07-16 | Japour Anthony J Director | Grant or award · Stock Options (Right to Buy) | +74,000 | 74,000 |
Page 3 of 8 · 145 trades